Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App





Werfen Introduces GEM Premier 7000 with iQM3 Blood Gas Testing System

By LabMedica International staff writers
Posted on 30 Jul 2024

At the ADLM 2024 Clinical Lab Expo, Werfen (Barcelona, Spain) is featuring its range of hemostasis, acute care, autoimmunity, transfusion and transplant systems, reagents, and digital solutions, and also unveiling its newest innovation in point-of-care (POC) detection. More...

As the number one source of preanalytical error, hemolysis accounts for up to 70% of all such errors. Despite its prevalence throughout the hospital, hemolysis is not visible in whole blood, and can often go unrecognized. The consequences of in vitro hemolysis can include inappropriate patient management, increased length of stay, and increased costs, among others. At this year’s ADLM Annual Meeting, Werfen is introducing the GEM Premier 7000 with Intelligent Quality Management 3 (iQM3), a breakthrough in blood gas testing that detects hemolysis at the POC.

The GEM Premier 7000 with iQM3 is a portable critical care system for use by health care professionals to rapidly analyze lithium heparinized whole blood samples at the point of health care delivery in a clinical setting and a central laboratory. The instrument provides quantitative measurements of pH, pCO2, pO2, sodium, potassium, chloride, ionized calcium, glucose, lactate, hematocrit, total bilirubin, and CO-Oximetry (tHb, O2Hb, COHb, MetHb, HHb, sO2) parameters from arterial, venous, or capillary lithium heparinized whole blood. These parameters, along with derived parameters, aid in the diagnosis of a patient’s acid/base status, electrolyte and metabolite balance and oxygen delivery capacity.

Werfen is providing a virtual reality laboratory experience to visitors at its booth where they can see 3D customized layouts of HemoCell specialized lab automation workcells for hemostasis labs of all sizes, shapes, and volumes. They can also see how Werfen’s comprehensive autoimmune diagnostics solution can help advance a lab’s capabilities by optimizing efficiency and enhancing clinical decision-making. Additionally, Werfen is presenting an industry workshop titled, Challenges in Pre-Analytical Error Detection: Impact of Hemolysis and Potential Solutions. The workshop will focus on the challenges in pre-analytical error detection, including hemolysis, its prevalence, and its impact on potassium and clinical outcomes. Current strategies and the company’s new technology to detect hemolysis for mitigating risks at the POC will also be discussed.

Related Links:
Werfen


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.